Efflux pump inhibitors as a promising adjunct therapy against drug resistant tuberculosis: a new strategy to revisit mycobacterial targets and repurpose old drugs

Research output: Contribution to journalReview articlepeer-review

14 Citations (Scopus)
63 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Efflux pump inhibitors as a promising adjunct therapy against drug resistant tuberculosis: a new strategy to revisit mycobacterial targets and repurpose old drugs'. Together they form a unique fingerprint.

Medicine & Life Sciences